Hybridyne Imaging Technologies Inc. rebrands to Hybridyne Health.

Terry Lall announced that as of today Hybridyne Imaging Technologies Inc. will be known as Hybridyne Health.

"The name change reflects a genuine and natural re-orientation in our core business over time, from initially being an Imaging R&D company; to our emergence in 2016 as a company with a strategic focus on applied health outcomes," said Mr Lall.

"Our concern for the sub-optimal imaging and treatment outcomes in prostate cancer, where we are accelerating the development of 2 new products, is just the start. We are also in the planning stages of a suite of new products to address other major Oncology imaging and treatment challenges."